C4 Therapeutics (CCCC) Total Non-Current Liabilities (2020)

C4 Therapeutics (CCCC) recorded quarterly Total Non-Current Liabilities of $123.1 million in Q3 2020.

C4 Therapeutics (CCCC) Total Non-Current Liabilities (2020) Analysis & Trends

C4 Therapeutics' Total Non-Current Liabilities history runs 1 years deep, the most recent figure standing at $123.1 million for Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Non-Current Liabilities (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	42,980.09
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	11.03 Mn
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	95.20 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	644,700.00
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	5.87 Bn
9	Abivax	91.96 Bn	91.96 Bn	-	64.76 Mn
10	C4 Therapeutics	520.69 Mn	285.02 Mn	-	-

Download Data

Date	Value
Sep 30, 2020	123.07 Mn